Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06878612
What this trial is testing

A Polyphenol Whole Tumor Cell Vaccine in Patients With Advanced Malignant Solid Tumors

Who this might be right for
PolyphenolsCancer VaccineAdvanced Solid Tumor
Xingchen Peng 9
Large-scale testing (Phase 3)UnknownNCT01914107
What this trial is testing

Real-time Cancer Pain Assessment and Intervention

Who this might be right for
MalignancyPain
Sun Yat-sen University 200
Large-scale testing (Phase 3)Looking for participantsNCT07044336
What this trial is testing

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Who this might be right for
Endometrial CancerMalignant Solid Tumour
AstraZeneca 800
Early research (Phase 1)Study completedNCT03009201
What this trial is testing

Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery

Who this might be right for
Advanced Soft Tissue SarcomaLocally Advanced AngiosarcomaLocally Advanced Leiomyosarcoma+24 more
OHSU Knight Cancer Institute 16
Testing effectiveness (Phase 2)Study completedNCT02807844
What this trial is testing

Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies

Who this might be right for
Triple Negative Breast CancerPancreatic CarcinomaMelanoma+1 more
Novartis Pharmaceuticals 141
Early research (Phase 1)Study completedNCT02546921
What this trial is testing

Phase I Study of MOv18 IgE

Who this might be right for
Human Cancers
Cancer Research UK 26
Testing effectiveness (Phase 2)Study completedNCT00006014
What this trial is testing

SU5416 in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
National Cancer Institute (NCI) 45
Early research (Phase 1)Looking for participantsNCT07656116
What this trial is testing

Platform Study of VSV-Based Recombinant Oncolytic Viruses for the Treatment of Advanced Malignant Tumors

Who this might be right for
Advanced Solid Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 27
Testing effectiveness (Phase 2)UnknownNCT01566799
What this trial is testing

Metformin Plus Neoadjuvant Chemotherapy in Breast Cancer

Who this might be right for
Locally Advanced Malignant Neoplasm
Instituto Nacional de Cancerologia de Mexico 60
Early research (Phase 1)Study completedNCT03908814
What this trial is testing

Phase I Clinical Trial of Human Anti-PD-L1 Antibody Injection (LDP) in Patients With Advanced Malignant Tumors

Who this might be right for
Advanced Tumors
Dragonboat Biopharmaceutical Company Limited 66
Early research (Phase 1)Not Yet RecruitingNCT07110363
What this trial is testing

A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

Who this might be right for
Advanced Malignant Solid TumorAdvanced Lung CancerNon-Small Cell Lung Cancer+1 more
Biotroy Therapeutics 58
Not applicableStudy completedNCT02575898
What this trial is testing

Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort Study

Who this might be right for
Primary Malignant Neoplasm of LungPrimary Malignant Neoplasm of Gastrointestinal Tract
Dartmouth-Hitchcock Medical Center 23
Early research (Phase 1)Active Not RecruitingNCT04616534
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors

Who this might be right for
Advanced Fallopian Tube CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+19 more
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)WithdrawnNCT05191004
What this trial is testing

Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC

Who this might be right for
Advanced Breast CancerMetastatic Breast CancerBreast Cancer+5 more
Nuvation Bio Inc.
Testing effectiveness (Phase 2)Study completedNCT00002973
What this trial is testing

Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma

Who this might be right for
Melanoma (Skin)
University of Wisconsin, Madison 34
Large-scale testing (Phase 3)Active Not RecruitingNCT03525873
What this trial is testing

Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy

Who this might be right for
Advanced Malignant NeoplasmMetastatic Malignant NeoplasmRecurrent Malignant Neoplasm
M.D. Anderson Cancer Center 212
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Testing effectiveness (Phase 2)Study completedNCT02265341
What this trial is testing

Ponatinib Hydrochloride in Treating Patients With Advanced Biliary Cancer With FGFR2 Fusions

Who this might be right for
Malignant Hepatobiliary Neoplasm
Mayo Clinic 12
Early research (Phase 1)Study completedNCT05162469
What this trial is testing

SHR-A1909 in Subjects With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 12
Early research (Phase 1)Looking for participantsNCT05906862
What this trial is testing

AMT-253 in Patients With Selected Advanced Solid Tumours

Who this might be right for
Advanced Solid Tumor
Multitude Therapeutics (Australia) Pty Ltd 54
Next Page